Finally, other studies have uncovered the role of CD38 in chronic autoimmune diseases, such as inflammatory bowel disease and multiple sclerosis, through various mechanisms [37], and studies evaluating the efficacy of daratumumab in these patient populations may be warranted. This evidence concerns the gene CD38 and multiple sclerosis.